Over-the-Counter Pain Medication Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1064691
  • May 2021
  • Pharmaceuticals
  • 132 Pages
The Over-the-Counter Pain Medication Market research report comprises of an overall in depth-analysis such as market drivers, opportunities, restraints, latest developments and trends, segmentation of the market, competitive analysis, global as well as regional analysis by showcasing how each of these factors can improve the further growth of the market on an overall perspective. The report also showcases the overall market value which includes the historic data (2018-2019) and forecast data (2020-2028) generated through the revenue (USD Mn)
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered GlaxoSmithKline plc., Bayer AG, Pfizer Inc., Sanofi, Boehringer Ingelheim GmbH, Merck Co. and Inc., Johnson and Johnson Services, Inc., Takeda Pharmaceutical Company Limited., Reckitt Benckiser Group plc, Teva Pharmaceutical Industries Ltd., ovartis AG, ylan N.V, bbott, straZeneca, un Pharmaceutical Industries Limited
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Coverage
With the beginning of the COVID-19 pandemic in early 2020, all major economies around the world enforced severe lockdown restrictions to curb the spread of the virus. Apart from a few sectors such as healthcare and related essential services, most of the industries suffered tremendously due to inability to function in a normal fashion. Moreover, even some of the essential sectors suffered due to delays caused by supply chain disruptions and other travel complexities. However, with massive vaccination drives in most of the developed economies, some of the economies across the world experienced economic recovery from 2021. The Over-the-Counter Pain Medication market is expected to gain momentum in such economies and probably recover some of the losses inflicted in the year 2020. With continued efforts towards curbing the virus in the developing economies, the Over-the-Counter Pain Medication market is expected to attain Pre COVID-19 levels by mid-2022.

Over-the-Counter Pain Medication Report’s Assessment
The research report is formulated such that it offers a deep understating on the market drivers that are assimilating the growth of the market, the market opportunities that are going to provide future growth factors for the market and the market restraints which showcase the reasons as to why the market can get hampered and dissimilated. All these factors are considered keeping in view the historic and forecast analysis which can enlighten the above mentioned factors.

Thereby at a glance a reader can understand all the factors and prospects of the Over-the-Counter Pain Medication market and how it can assimilate and dissimilate based on each of the factors and figures mentioned in the report

Over-the-Counter Pain Medication Market Competitive and Premeditated Analysis
In the Over-the-Counter Pain Medication report major factors such latest tactical developments, competitors, research and development, participation of each region in the market and the competition among them, the latest news regarding company acquisitions and product launch, revenue of the competitors as well as the key offerings they provide all these factors are mentioned in the report with reasons to justify and understand them in depth.

The readers and purchaser of the Over-the-Counter Pain Medication research report can gain a comprehensive understanding of the market competition, the revenue of each major players and their contribution towards the market, attractive proposition analysis is provided in the report which sub divides the segments with respect to the largest segment that has contributed to the market growth and the fastest growing segment based on the size of the market as well as its overall appeal.
 
Major Key Players for Global Over-the-Counter Pain Medication Market:
The Over-the-Counter Pain Medication market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. GlaxoSmithKline plc., Bayer AG, Pfizer Inc., Sanofi, Boehringer Ingelheim GmbH, Merck Co. and Inc., Johnson and Johnson Services, Inc., Takeda Pharmaceutical Company Limited., Reckitt Benckiser Group plc, Teva Pharmaceutical Industries Ltd., ovartis AG, ylan N.V, bbott, straZeneca, un Pharmaceutical Industries Limited

The Over-the-Counter Pain Medication market report showcases vast potentials of growth and assimilation which is going to provide the industry numerous opportunities to grow and generate revenue by understanding the segments and which segment is a potential part to increase the disposable income in the present and upcoming years.

Over-the-Counter Pain Medication Market Segmentation Analysis:
Each of the segment is explained in brief along with the revenue it generates for the market based on the historic and forecast data by highlighting the largest segment and the fastest growing segment with reasons to justify it.

The Global segmentation of the Over-the-Counter Pain Medication market:
By Drug Type
Acetaminophen
Nonsteroidal Anti-inflammatory Drugs
NSAIDs
Route of Administration
Oral
Topical
Parenteral
Distribution Channel
Hospital Pharmacies
Retail Pharmacies
E-commerce
Home Care


Regional Analysis of the Over-the-Counter Pain Medication market:
The Over-the-Counter Pain Medication market is dived based on different regions such as North America, Europe, Asia Pacific, Latin America and the Middle East and Africa. And the analysis of each region is provided by highlighting the largest contribution region, the fastest growing region and the factors that is keeping the market active in the other regions is also mentioned in depth. Each regional segment also comprises of the revenue each segment holds in a specific region with reasons to justify the values.

By Regions:
  • North America (U.S and Canada)
  • Europe (U.K., Germany and France)
  • Asia Pacific (China, India and Japan)
  • Latin America (Mexico and Brazil)
  • Middle East and Africa (GCC Countries and South Africa)
 


Major Factors Included and highlighted in the Over-the-Counter Pain Medication report are as follows:
  • The overall market value along with historic and future data analysis.
  • The Growth drivers, opportunities and restraints are mention in detail.
  • The size of the entire Over-the-Counter Pain Medication market on a global perspective.
  • The CAGR value of the overall market from 2020 to 2028.
  • COVID-19 impact on the Over-the-Counter Pain Medication market and how it is coping up with the situation.
  • Major competitors and their contribution towards the market.
  • The segmentation analysis is included which provides a clear picture of the market bifurcation.
  • Tables and graphs that can easily been understood at a glance
  • Latest trends and news related to the Over-the-Counter Pain Medication market is included in the report.
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Over-the-Counter Pain Medication market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Over-the-Counter Pain Medication market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Over-the-Counter Pain Medication market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Over-the-Counter Pain Medication market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Over-the-Counter Pain Medication market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • GlaxoSmithKline plc.
  • Bayer AG
  • Pfizer Inc.
  • Sanofi
  • Boehringer Ingelheim GmbH
  • Merck Co. and Inc.
  • Johnson and Johnson Services, Inc.
  • Takeda Pharmaceutical Company Limited.
  • Reckitt Benckiser Group plc
  • Teva Pharmaceutical Industries Ltd.
  • ovartis AG
  • ylan N.V
  • bbott
  • straZeneca
  • un Pharmaceutical Industries Limited
  • Acetaminophen
  • Nonsteroidal Anti-inflammatory Drugs
  • NSAIDs
  • Hospital Pharmacies
  • Retail Pharmacies
  • E-commerce
  • Home Care

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Over-the-Counter Pain Medication Market Snapshot
          2.1.1. Global Over-the-Counter Pain Medication Market By Drug Type,2019
               2.1.1.1.Acetaminophen
               2.1.1.2.Nonsteroidal Anti-inflammatory Drugs
               2.1.1.3.NSAIDs
          2.1.2. Global Over-the-Counter Pain Medication Market By Distribution Channel,2019
               2.1.2.1.Hospital Pharmacies
               2.1.2.2.Retail Pharmacies
               2.1.2.3.E-commerce
               2.1.2.4.Home Care
          2.1.3. Global Over-the-Counter Pain Medication Market By End-use,2019
          2.1.4. Global Over-the-Counter Pain Medication Market By Geography,2019

3. Global Over-the-Counter Pain Medication Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Over-the-Counter Pain Medication Market Size (US$), By Drug Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Drug Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Drug Type, 2020
     4.2. Global Over-the-Counter Pain Medication Market Size (US$), By Drug Type, 2018 – 2028

5. Global Over-the-Counter Pain Medication Market Size (US$), By Distribution Channel, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Distribution Channel, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Distribution Channel, 2020
     5.2. Global Over-the-Counter Pain Medication Market Size (US$), By Distribution Channel, 2018 – 2028

6. Global Over-the-Counter Pain Medication Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Over-the-Counter Pain Medication Market Size (US$), By End-use, 2018 – 2028

7. Global Over-the-Counter Pain Medication Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Over-the-Counter Pain Medication Market Analysis, 2018 – 2028 
          7.2.1. North America Over-the-Counter Pain Medication Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Over-the-Counter Pain Medication Market Size (US$), By Drug Type, 2018 – 2028
          7.2.3. North America Over-the-Counter Pain Medication Market Size (US$), By Distribution Channel, 2018 – 2028
          7.2.4. North America Over-the-Counter Pain Medication Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Over-the-Counter Pain Medication Market Analysis, 2018 – 2028 
          7.3.1.  Europe Over-the-Counter Pain Medication Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Over-the-Counter Pain Medication Market Size (US$), By Drug Type, 2018 – 2028
          7.3.3. Europe Over-the-Counter Pain Medication Market Size (US$), By Distribution Channel, 2018 – 2028
          7.3.4. Europe Over-the-Counter Pain Medication Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Over-the-Counter Pain Medication Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Over-the-Counter Pain Medication Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Over-the-Counter Pain Medication Market Size (US$), By Drug Type, 2018 – 2028
          7.4.3. Asia Pacific Over-the-Counter Pain Medication Market Size (US$), By Distribution Channel, 2018 – 2028
          7.4.4. Asia Pacific Over-the-Counter Pain Medication Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Over-the-Counter Pain Medication Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Over-the-Counter Pain Medication Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Over-the-Counter Pain Medication Market Size (US$), By Drug Type, 2018 – 2028
          7.5.3. Latin America Over-the-Counter Pain Medication Market Size (US$), By Distribution Channel, 2018 – 2028
          7.5.4. Latin America Over-the-Counter Pain Medication Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Over-the-Counter Pain Medication Market Analysis, 2018 – 2028 
          7.6.1.  MEA Over-the-Counter Pain Medication Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Over-the-Counter Pain Medication Market Size (US$), By Drug Type, 2018 – 2028
          7.6.3. MEA Over-the-Counter Pain Medication Market Size (US$), By Distribution Channel, 2018 – 2028
          7.6.4. MEA Over-the-Counter Pain Medication Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Over-the-Counter Pain Medication Providers
        8.4.1 GlaxoSmithKline plc.
                8.4.1.1 Business Description
                8.4.1.2 GlaxoSmithKline plc. Geographic Operations
                8.4.1.3 GlaxoSmithKline plc. Financial Information
                8.4.1.4 GlaxoSmithKline plc. Product Positions/Portfolio
                8.4.1.5 GlaxoSmithKline plc. Key Developments
        8.4.2 Bayer AG
                8.4.2.1 Business Description
                8.4.2.2 Bayer AG Geographic Operations
                8.4.2.3 Bayer AG Financial Information
                8.4.2.4 Bayer AG Product Positions/Portfolio
                8.4.2.5 Bayer AG Key Developments
        8.4.3 Pfizer Inc.
                8.4.3.1 Business Description
                8.4.3.2 Pfizer Inc. Geographic Operations
                8.4.3.3 Pfizer Inc. Financial Information
                8.4.3.4 Pfizer Inc. Product Positions/Portfolio
                8.4.3.5 Pfizer Inc. Key Developments
        8.4.4 Sanofi
                8.4.4.1 Business Description
                8.4.4.2 Sanofi Geographic Operations
                8.4.4.3 Sanofi Financial Information
                8.4.4.4 Sanofi Product Positions/Portfolio
                8.4.4.5 Sanofi Key Developments
        8.4.5 Boehringer Ingelheim GmbH
                8.4.5.1 Business Description
                8.4.5.2 Boehringer Ingelheim GmbH Geographic Operations
                8.4.5.3 Boehringer Ingelheim GmbH Financial Information
                8.4.5.4 Boehringer Ingelheim GmbH Product Positions/Portfolio
                8.4.5.5 Boehringer Ingelheim GmbH Key Developments
        8.4.6 Merck Co. and Inc.
                8.4.6.1 Business Description
                8.4.6.2 Merck Co. and Inc. Geographic Operations
                8.4.6.3 Merck Co. and Inc. Financial Information
                8.4.6.4 Merck Co. and Inc. Product Positions/Portfolio
                8.4.6.5 Merck Co. and Inc. Key Developments
        8.4.7 Johnson and Johnson Services, Inc.
                8.4.7.1 Business Description
                8.4.7.2 Johnson and Johnson Services, Inc. Geographic Operations
                8.4.7.3 Johnson and Johnson Services, Inc. Financial Information
                8.4.7.4 Johnson and Johnson Services, Inc. Product Positions/Portfolio
                8.4.7.5 Johnson and Johnson Services, Inc. Key Developments
        8.4.8 Takeda Pharmaceutical Company Limited.
                8.4.8.1 Business Description
                8.4.8.2 Takeda Pharmaceutical Company Limited. Geographic Operations
                8.4.8.3 Takeda Pharmaceutical Company Limited. Financial Information
                8.4.8.4 Takeda Pharmaceutical Company Limited. Product Positions/Portfolio
                8.4.8.5 Takeda Pharmaceutical Company Limited. Key Developments
        8.4.9 Reckitt Benckiser Group plc
                8.4.9.1 Business Description
                8.4.9.2 Reckitt Benckiser Group plc Geographic Operations
                8.4.9.3 Reckitt Benckiser Group plc Financial Information
                8.4.9.4 Reckitt Benckiser Group plc Product Positions/Portfolio
                8.4.9.5 Reckitt Benckiser Group plc Key Developments
        8.4.10 Teva Pharmaceutical Industries Ltd.
                8.4.10.1 Business Description
                8.4.10.2 Teva Pharmaceutical Industries Ltd. Geographic Operations
                8.4.10.3 Teva Pharmaceutical Industries Ltd. Financial Information
                8.4.10.4 Teva Pharmaceutical Industries Ltd. Product Positions/Portfolio
                8.4.10.5 Teva Pharmaceutical Industries Ltd. Key Developments
        8.4.11 ovartis AG
                8.4.11.1 Business Description
                8.4.11.2 ovartis AG Geographic Operations
                8.4.11.3 ovartis AG Financial Information
                8.4.11.4 ovartis AG Product Positions/Portfolio
                8.4.11.5 ovartis AG Key Developments
        8.4.12 ylan N.V
                8.4.12.1 Business Description
                8.4.12.2 ylan N.V Geographic Operations
                8.4.12.3 ylan N.V Financial Information
                8.4.12.4 ylan N.V Product Positions/Portfolio
                8.4.12.5 ylan N.V Key Developments
        8.4.13 bbott
                8.4.13.1 Business Description
                8.4.13.2 bbott Geographic Operations
                8.4.13.3 bbott Financial Information
                8.4.13.4 bbott Product Positions/Portfolio
                8.4.13.5 bbott Key Developments
        8.4.14 straZeneca
                8.4.14.1 Business Description
                8.4.14.2 straZeneca Geographic Operations
                8.4.14.3 straZeneca Financial Information
                8.4.14.4 straZeneca Product Positions/Portfolio
                8.4.14.5 straZeneca Key Developments
        8.4.15 un Pharmaceutical Industries Limited
                8.4.15.1 Business Description
                8.4.15.2 un Pharmaceutical Industries Limited Geographic Operations
                8.4.15.3 un Pharmaceutical Industries Limited Financial Information
                8.4.15.4 un Pharmaceutical Industries Limited Product Positions/Portfolio
                8.4.15.5 un Pharmaceutical Industries Limited Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Over-the-Counter Pain Medication Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Over-the-Counter Pain Medication Market Revenue, By Drug Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Over-the-Counter Pain Medication Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Over-the-Counter Pain Medication Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Over-the-Counter Pain Medication Market Revenue, By Drug Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Over-the-Counter Pain Medication Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Over-the-Counter Pain Medication Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Over-the-Counter Pain Medication Market Revenue, By Drug Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Over-the-Counter Pain Medication Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Over-the-Counter Pain Medication Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Over-the-Counter Pain Medication Market Revenue, By Drug Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Over-the-Counter Pain Medication Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Over-the-Counter Pain Medication Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Over-the-Counter Pain Medication Market Revenue, By Drug Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Over-the-Counter Pain Medication Market Revenue, By Distribution Channel, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Over-the-Counter Pain Medication Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Over-the-Counter Pain Medication: Market Segmentation 
FIG. 2 Global Over-the-Counter Pain Medication Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Over-the-Counter Pain Medication Market, By Drug Type, 2019 (US$ Mn) 
FIG. 5 Global Over-the-Counter Pain Medication Market, By Distribution Channel, 2019 (US$ Mn) 
FIG. 6 Global Over-the-Counter Pain Medication Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Over-the-Counter Pain Medication Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Over-the-Counter Pain Medication Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Over-the-Counter Pain Medication Providers, 2019
FIG. 11 Global Over-the-Counter Pain Medication Market Revenue Contribution, By Drug Type, 2019 & 2028 (Value %) 
FIG. 12 Global Over-the-Counter Pain Medication Market Revenue Contribution, By Distribution Channel, 2019 & 2028 (Value %) 
FIG. 13 Global Over-the-Counter Pain Medication Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Over-the-Counter Pain Medication Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Over-the-Counter Pain Medication Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Over-the-Counter Pain Medication Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Over-the-Counter Pain Medication Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Over-the-Counter Pain Medication Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Over-the-Counter Pain Medication market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Over-the-Counter Pain Medication Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Over-the-Counter Pain Medication Market Value, By Segment1, 2018 – 2028
TABLE  North America Over-the-Counter Pain Medication Market Value, By Segment2, 2018 – 2028
TABLE  North America Over-the-Counter Pain Medication Market Value, By Country, 2018 – 2028
TABLE  Europe Over-the-Counter Pain Medication Market Value, By Segment1, 2018 – 2028
TABLE  Europe Over-the-Counter Pain Medication Market Value, By Segment2, 2018 – 2028
TABLE  Europe Over-the-Counter Pain Medication Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Over-the-Counter Pain Medication Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Over-the-Counter Pain Medication Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Over-the-Counter Pain Medication Market Value, By Country, 2018 – 2028
TABLE  Latin America Over-the-Counter Pain Medication Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Over-the-Counter Pain Medication Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Over-the-Counter Pain Medication Market Value, By Country, 2018 – 2028
TABLE  MEA Over-the-Counter Pain Medication Market Value, By Segment1, 2018 – 2028
TABLE  MEA Over-the-Counter Pain Medication Market Value, By Segment2, 2018 – 2028
TABLE  MEA Over-the-Counter Pain Medication Market Value, By Country, 2018 – 2028
TABLE  GlaxoSmithKline plc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Bayer AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Pfizer Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Sanofi: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Boehringer Ingelheim GmbH: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Merck Co. and Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Johnson and Johnson Services, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Takeda Pharmaceutical Company Limited.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Reckitt Benckiser Group plc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Teva Pharmaceutical Industries Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  ovartis AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  ylan N.V: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  bbott: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  straZeneca: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  un Pharmaceutical Industries Limited: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Over-the-Counter Pain Medication Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Over-the-Counter Pain Medication Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Over-the-Counter Pain Medication Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Over-the-Counter Pain Medication Market, By Geography, 2019 (US$ Mn)
FIG.  Global Over-the-Counter Pain Medication Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Over-the-Counter Pain Medication Providers, 2016
FIG.  Global Over-the-Counter Pain Medication Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Nonsteroidal Anti-inflammatory Drugs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global NSAIDs Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Over-the-Counter Pain Medication Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Retail Pharmacies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global E-commerce Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Home Care Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Over-the-Counter Pain Medication Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Over-the-Counter Pain Medication Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Over-the-Counter Pain Medication Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Over-the-Counter Pain Medication Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Over-the-Counter Pain Medication Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Over-the-Counter Pain Medication Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Over-the-Counter Pain Medication Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Over-the-Counter Pain Medication Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Over-the-Counter Pain Medication Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Over-the-Counter Pain Medication Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Over-the-Counter Pain Medication Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Over-the-Counter Pain Medication Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Over-the-Counter Pain Medication Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Over-the-Counter Pain Medication Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Over-the-Counter Pain Medication Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Over-the-Counter Pain Medication Market Value, 2018 – 2028, (US$ Mn)